These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 29216988)

  • 1. Catheter Ablation of Ventricular Tachycardia in Structural Heart Disease: Indications, Strategies, and Outcomes-Part II.
    Dukkipati SR; Koruth JS; Choudry S; Miller MA; Whang W; Reddy VY
    J Am Coll Cardiol; 2017 Dec; 70(23):2924-2941. PubMed ID: 29216988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catheter Ablation of Ventricular Tachycardia in Structurally Normal Hearts: Indications, Strategies, and Outcomes-Part I.
    Dukkipati SR; Choudry S; Koruth JS; Miller MA; Whang W; Reddy VY
    J Am Coll Cardiol; 2017 Dec; 70(23):2909-2923. PubMed ID: 29216987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catheter ablation for ventricular tachycardia in structural heart disease.
    Macintyre CJ; Sapp JL
    Can J Cardiol; 2014 Feb; 30(2):244-6. PubMed ID: 24373758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients treated with catheter ablation for ventricular tachycardia after an ICD shock have lower long-term rates of death and heart failure hospitalization than do patients treated with medical management only.
    Bunch TJ; Weiss JP; Crandall BG; Day JD; May HT; Bair TL; Osborn JS; Mallender C; Fischer A; Brunner KJ; Mahapatra S
    Heart Rhythm; 2014 Apr; 11(4):533-40. PubMed ID: 24333283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Catheter ablation of ventricular tachycardia in patients with structural heart disease].
    Lindemann F; Darma A; Hindricks G
    Herz; 2022 Apr; 47(2):129-134. PubMed ID: 35262743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catheter ablation for ventricular tachycardia in patients with an implantable cardioverter defibrillator (CALYPSO) pilot trial.
    Al-Khatib SM; Daubert JP; Anstrom KJ; Daoud EG; Gonzalez M; Saba S; Jackson KP; Reece T; Gu J; Pokorney SD; Granger CB; Hess PL; Mark DB; Stevenson WG
    J Cardiovasc Electrophysiol; 2015 Feb; 26(2):151-7. PubMed ID: 25332150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained ventricular tachycardia in structural heart disease.
    Hadid C
    Cardiol J; 2015; 22(1):12-24. PubMed ID: 25299497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial.
    Kuck KH; Schaumann A; Eckardt L; Willems S; Ventura R; Delacrétaz E; Pitschner HF; Kautzner J; Schumacher B; Hansen PS;
    Lancet; 2010 Jan; 375(9708):31-40. PubMed ID: 20109864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catheter Ablation of Post-Infarct VT: Mechanisms, Strategies and Outcomes.
    Emami M; Morton JB; Chan KH; Roberts-Thomson KC
    Heart Lung Circ; 2019 Jan; 28(1):76-83. PubMed ID: 30482686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Frequent ventricular tachycardias: antiarrhythmic drug treatment or catheter ablation?].
    Tanner H; Hindricks G; Kottkamp H
    Herz; 2005 Nov; 30(7):613-8. PubMed ID: 16333587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Indications for catheter ablation of ventricular tachycardia].
    Deneke T; Israel CW; Krug J; Nentwich K; Müller P; Mügge A; Schade A
    Dtsch Med Wochenschr; 2013 Sep; 138(39):1952-6. PubMed ID: 24046136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catheter ablation for ventricular tachycardia (VT) in patients with ischemic heart disease: a systematic review and a meta-analysis of randomized controlled trials.
    Patel D; Hasselblad V; Jackson KP; Pokorney SD; Daubert JP; Al-Khatib SM
    J Interv Card Electrophysiol; 2016 Mar; 45(2):111-7. PubMed ID: 26695501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Catheter ablation of ventricular tachycardia : What have we achieved?].
    Konrad T; Hoffmann BA; Rostock T
    Herz; 2017 Apr; 42(2):132-137. PubMed ID: 28229198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping and ablation procedures for the treatment of ventricular tachycardia.
    Killu AM; Mulpuru SK; Asirvatham SJ
    Expert Rev Cardiovasc Ther; 2016 Sep; 14(9):1071-87. PubMed ID: 27269734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ventricular tachycardia ablation remains treatment of last resort in structural heart disease: argument for earlier intervention.
    Frankel DS; Mountantonakis SE; Robinson MR; Zado ES; Callans DJ; Marchlinski FE
    J Cardiovasc Electrophysiol; 2011 Oct; 22(10):1123-8. PubMed ID: 21539642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ablation of Ventricular Tachycardia in Congenital and Infiltrative Heart Disease.
    Wijnmaalen AP; Zeppenfeld K
    Card Electrophysiol Clin; 2017 Mar; 9(1):107-117. PubMed ID: 28167078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Radiofrequency ablation in ventricular tachycardia: an alternative to implanted cardioverter defibrillator?].
    Noble S; Shah D
    Rev Med Suisse; 2006 May; 2(67):1406, 1408-11. PubMed ID: 16786957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of persistent ventricular tachycardia: Drugs or ablation?
    MacIntyre CJ; Sapp JL
    Trends Cardiovasc Med; 2017 Oct; 27(7):506-513. PubMed ID: 28625728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of catheter ablation in the management of ventricular tachycardia.
    Tanawuttiwat T; Nazarian S; Calkins H
    Eur Heart J; 2016 Feb; 37(7):594-609. PubMed ID: 26324538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.